1 January 2023 false No description of principal activity Taxfiler 2024.5 12450812business:PrivateLimitedCompanyLtd2023-01-012023-12-31 124508122022-12-31 124508122023-01-012023-12-31 12450812business:AuditExempt-NoAccountantsReport2023-01-012023-12-31 12450812business:FilletedAccounts2023-01-012023-12-31 124508122023-12-31 12450812business:Director12023-01-012023-12-31 12450812business:RegisteredOffice2023-01-012023-12-31 124508122022-12-31 12450812core:WithinOneYear2023-12-31 12450812core:WithinOneYear2022-12-31 12450812core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 12450812core:ShareCapitalcore:PreviouslyStatedAmount2022-12-31 12450812core:SharePremiumcore:PreviouslyStatedAmount2023-12-31 12450812core:SharePremiumcore:PreviouslyStatedAmount2022-12-31 12450812core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 12450812core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 12450812core:PreviouslyStatedAmount2023-12-31 12450812core:PreviouslyStatedAmount2022-12-31 12450812business:SmallEntities2023-01-012023-12-31 12450812countries:EnglandWales2023-01-012023-12-31 12450812core:PlantMachinery2023-01-012023-12-31 12450812core:PlantMachinery2022-12-31 12450812core:PlantMachinery2023-12-31 12450812core:AdditionsToInvestments2023-12-31 12450812core:DisposalsRepaymentsInvestments2023-12-31 124508122022-01-012022-12-31 iso4217:GBP xbrli:pure
Company Registration No. 12450812 (England and Wales)
Bioactive Pharma Ltd Unaudited accounts for the year ended 31 December 2023
Bioactive Pharma Ltd Unaudited accounts Contents
Page
- 2 -
Bioactive Pharma Ltd Company Information for the year ended 31 December 2023
Director
K L Aspinall Nessling
Company Number
12450812 (England and Wales)
Registered Office
14 Whyke Road Chichester PO19 7AN England
- 3 -
Bioactive Pharma Ltd Statement of financial position as at 31 December 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Tangible assets
5,922 
2,488 
Investments
566,277 
875,213 
572,199 
877,701 
Current assets
Debtors
319,439 
857 
Cash at bank and in hand
26,334 
92,479 
345,773 
93,336 
Creditors: amounts falling due within one year
(76,539)
(143,838)
Net current assets/(liabilities)
269,234 
(50,502)
Net assets
841,433 
827,199 
Capital and reserves
Called up share capital
97 
95 
Share premium
1,044,974 
944,976 
Profit and loss account
(203,638)
(117,872)
Shareholders' funds
841,433 
827,199 
For the year ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 17 July 2024 and were signed on its behalf by
K L Aspinall Nessling Director Company Registration No. 12450812
- 4 -
Bioactive Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
1
Statutory information
Bioactive Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12450812. The registered office is 14 Whyke Road, Chichester, PO19 7AN, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Preparation of consolidated financial statements
The financial statements contain information about Bioactive Pharma Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.
Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
Revenue Recognition
Revenue, described as turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes
Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight line over 3 years
- 5 -
Bioactive Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
4
Tangible fixed assets
Plant & machinery 
£ 
Cost or valuation
At cost 
At 1 January 2023
3,713 
Additions
7,869 
Disposals
(1,804)
At 31 December 2023
9,778 
Depreciation
At 1 January 2023
1,225 
Charge for the year
3,226 
On disposals
(595)
At 31 December 2023
3,856 
Net book value
At 31 December 2023
5,922 
At 31 December 2022
2,488 
5
Investments
Subsidiary undertakings 
£ 
Valuation at 1 January 2023
875,213 
Additions
131,970 
Disposals
(440,906)
Valuation at 31 December 2023
566,277 
6
Debtors
2023 
2022 
£ 
£ 
Amounts falling due within one year
Trade debtors
291,475 
- 
Accrued income and prepayments
27,962 
- 
Other debtors
2 
857 
319,439 
857 
7
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
VAT
(3,094)
- 
Trade creditors
47,846 
18,207 
Taxes and social security
26,400 
36,341 
Other creditors
- 
50,000 
Loans from directors
109 
37,190 
Accruals
5,278 
2,100 
76,539 
143,838 
- 6 -
Bioactive Pharma Ltd Notes to the Accounts for the year ended 31 December 2023
8
Transactions with related parties
Interest is not being charged on the director loan included within creditors.
9
Average number of employees
During the year the average number of employees was 4 (2022: 1).
- 7 -